Возможность использования продуктов эмбриофетоплацентарного комплекса как корректора апоптотических процессов при аутоиммунных заболеваниях

Возможность использования продуктов эмбриофетоплацентарного комплекса как корректора апоптотических процессов при аутоиммунных заболеваниях

The authors have studied the activity of immune competent cells in an experimental model of rheumatoid arthritis in mice. There was demonstrated the possibility to apply the products of embryo fetoplacental complex (PEFPC) to modulate the apoptotic processes under autoimmune diseases (AIDs). 

Saved in:
Bibliographic Details
Date:2003
Main Authors: Goltsev, A. N., Grischenko, V. I., Rassokha, I. V., Ostankov, M. V.
Format: Article
Language:English
Published: Publishing House ‘Akademperiodyka’ of the National Academy of Sciences of Ukraine; Institute for Problems of Cryobiology and Cryomedicine 2003
Subjects:
апоптоз
ревматоїдний артрит
продукти ембріофетоплацентарного комплексу
Online Access:https://cryo.org.ua/journal/index.php/probl-cryobiol-cryomed/article/view/1077
Tags: Add Tag
No Tags, Be the first to tag this record!
Journal Title:Problems of Cryobiology and Cryomedicine

Institution

Problems of Cryobiology and Cryomedicine
Description
Summary:The authors have studied the activity of immune competent cells in an experimental model of rheumatoid arthritis in mice. There was demonstrated the possibility to apply the products of embryo fetoplacental complex (PEFPC) to modulate the apoptotic processes under autoimmune diseases (AIDs). 

Similar Items